San Francisco, CANCT07226440Now EnrollingIRB Ready

Toxicant Exposure Clinical Trial in San Francisco, CA

Access cutting-edge toxicant exposure treatment through this phase 1/2 clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Francisco

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access toxicant exposure specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related toxicant exposure treatment provided free

Apply for This San Francisco Location

Check if you qualify for this toxicant exposure clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Toxicant Exposure Study in San Francisco

This randomized, placebo-controlled crossover trial will test the feasibility and acceptability of using colesevelam in male firefighters with high per- and polyfluoroalkyl substances (PFAS) exposure. This trial will also explore whether colesevelam lowers blood PFAS levels and urine environmental toxicant and mold mycotoxin levels.

Sponsor: University of California, San Francisco

Who Can Participate

Inclusion Criteria

Male firefighter, active or retired
California resident
Age 18 or older
English-speaking
Access to a reliable internet connection
Willing to attend 3 in-person study visits in the San Francisco Bay Area over about 6.5 months
Willing to receive weekly text message reminders to complete online surveys
Willing to complete a mail-based, at-home finger-prick blood test
Willing to take 3 tablets (each tablet about the size of a multivitamin) orally twice daily for a total of 6 months
Evaluated by study team to have an elevated risk of PFAS exposure (e.g., duration of firefighting service, prior NASEM-7 result greater than or equal to 10 ng/mL)

Exclusion Criteria

Gastroparesis or other severe gastrointestinal motility disorders
Bowel obstruction
History of major gastrointestinal tract surgery
Dysphagia or difficulty swallowing (due to tablet size)
History of hypertriglyceridemia (triglycerides exceeding 500 mg/dL)
History of hypertriglyceridemia-induced pancreatitis
Type 1 or 2 diabetes
History of fat-soluble vitamin deficiencies, i.e., vitamins A, D, E, or K
Phenylketonuria
History of known bleeding/clotting disorders
Medications or treatments that may impact the excretion of PFAS, such as activated charcoal, other bile acid sequestrants, chelation therapies, etc.
Unalterable plans to donate blood or plasma during the study participation period

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT07226440) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Toxicant Exposure Treatment Options in San Francisco, CA

If you're searching for toxicant exposure treatment options in San Francisco, CA, this clinical trial (NCT07226440) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced toxicant exposure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all toxicant exposure clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in San Francisco, CA

See all interstitial cystitis clinical trials recruiting in San Francisco — not just this study.

Browse Interstitial Cystitis Trials in San Francisco →

Browse More Trials by Condition

Interstitial Cystitis TrialsXeroderma Pigmentosum TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA